Hisamitsu Pharmaceutical Co Inc operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hisamitsu Pharmaceutical Co Inc with three other
pharmaceutical manufacturers in Asia:
Daito Pharmaceutical Company Limited
sales of 36.37 billion Japanese Yen [US$351.70 million]
of which 60%
was Drug Substance),
Kissei Pharmaceutical Company Limited
(71.29 billion Japanese Yen [US$689.41 million]
of which 87%
was Pharmaceutical Products), and
based in India
(142.08 billion Indian Rupees [US$2.13 billion]
of which 100%
Hisamitsu Pharmaceutical Co Inc reported sales of ¥161.85 billion (US$1.57 billion)
February of 2016.
increase of 3.3%
versus 2015, when the company's sales were ¥156.74 billion.
Sales at Hisamitsu Pharmaceutical Co Inc have increased during each of the previous five years
(and since 2011, sales have increased a total of 18%).